Current data suggest that the rate of breastfeeding in the United States is far below the recommendation of the American Academy of Pediatrics that all infants be exclusively breastfed for the first 6 ...
KETABET™, a patented combination formulation of FDA-approved ketamine and betaine anhydrous, has been shown in research to enhance the antidepressant effect while having the potential to reduce the ...
Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another. Fixed-dose combination (FDC) drugs offer a number of benefits to drug manufacturers, patients ...
Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide. (Image Credits: Pixabay) Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a ...
PHOENIX--(BUSINESS WIRE)--PanTheryx, an integrative digestive and immune health company, today announced the expansion of its formulation capabilities to now include colostrum plus probiotic ...
NEW YORK, Aug. 29, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced its approval of a subcutaneous formulation of Leqembi (lecanemab), branded as Leqembi Iqlik, for ...
TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results